Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 21, 2022 | Series A | $60M | 1 | General Catalyst | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Catalyst | Yes | Series A |